Quality of Life and Treatment Outcomes in RRMM Patients Receiving Advanced vs. Conventional Immunotherapies
Conditions
- Multiple Myeloma, Relapsed
- Multiple Myeloma (MM)
Interventions
- DRUG: Bispecific antibody
- DRUG: Antibody-Drug Conjugate
- DRUG: Monoclonal antibody
- DRUG: Proteasome Inhibitor
- DRUG: IMiD treatment
- DRUG: CAR-T Therapy
Sponsor
Sung-Soo Park
Collaborators